The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Validation of the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer (CRPC): Data from TRUMPET.
 
Scott Flanders
Employment - Astellas Pharma
Stock and Other Ownership Interests - Johnson & Johnson
Travel, Accommodations, Expenses - Astellas Pharma
 
Samuel D. Wilson
Employment - Astellas Pharma
Stock and Other Ownership Interests - Baxter (I)
Research Funding - Astellas Pharma
 
Janet Kim
Employment - Astellas Pharma
Research Funding - Astellas Pharma
 
Sheldon Greenfield
Research Funding - Astellas Pharma
 
Sherrie H. Kaplan
Research Funding - Astellas Pharma
 
John Billimek
Consulting or Advisory Role - Lynx Biosciences
 
Arie Barlev
Employment - Medivation
Stock and Other Ownership Interests - Medivation
 
Elaine Wong
Employment - Medivation
 
Daniel W. Lin
Consulting or Advisory Role - Astellas Pharma; Bayer; Myriad Genetics
Research Funding - GenomeDx (Inst); Genomic Health (Inst)
 
Lawrence Ivan Karsh
Stock and Other Ownership Interests - Swan Valley Medical
Honoraria - Astellas Pharma; Bayer; Dendreon; Janssen; Medivation/Astellas
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen; Medivation/Astellas
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Dendreon; Janssen; Medivation
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Dendreon (Inst); Janssen (Inst); Medivation/Astellas (Inst); Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; dendreon; Janssen; Medivation/Astellas; Spectrum Pharmaceuticals
 
David I. Quinn
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Exelixis; Genentech/Roche; Merck Serono; Merck Sharp & Dohme; Novartis; Peloton Therapeutics; Pfizer; Piramal Life Science; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Exelixis; Genentech/Roche; Merck Serono; Merck Sharp & Dohme; Novartis; Peloton Therapeutics; Pfizer; Piramal Life Science; Sanofi
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Millennium (Inst); Sanofi (Inst)
 
Daniel H. Shevrin
Speakers' Bureau - Astellas Pharma; Bayer
 
Neal D. Shore
Consulting or Advisory Role - Bayer; Dendreon; Ferring; Janssen Scientific Affairs; Medivation/Astellas; Sanofi; Takeda; Tolmar
 
James Thomas Symanowski
Consulting or Advisory Role - Antigen Express; Astellas Pharma; Endocyte (Inst); Lilly; ProNAi; Ra Pharma (Inst)
 
David F. Penson
Consulting or Advisory Role - Astellas Pharma; Dendreon; Medivation
Research Funding - Astellas Pharma (Inst); Medivation (Inst)